C - Chemistry – Metallurgy – 07 – K
Patent
C - Chemistry, Metallurgy
07
K
C07K 5/027 (2006.01) A61K 38/06 (2006.01) A61K 39/395 (2006.01) A61K 47/48 (2006.01) A61P 31/00 (2006.01) A61P 35/00 (2006.01) A61P 37/00 (2006.01) C07K 5/00 (2006.01) C07K 16/00 (2006.01) C07K 16/28 (2006.01) C07K 16/30 (2006.01) C12Q 1/04 (2006.01) G01N 33/574 (2006.01)
Patent
CA 2543888
Auristatin peptides, including MeVal-Val-Dil-Dap-Norephedrine (MMAE) and MeVal- Val-Dil-Dap-Phe (MMAF), were prepared and attached to Ligands through various linkers, including maleimidocaproyl-val-cit-PAB. The resulting ligand drug conjugates were active in vitro and in vivo.
La présente invention a trait à des peptides d'auristatine, comprenant de la MeVal-Val-Dil-Dap-phénylpropanolamine (MMAE) de la MeVal-Val-Dil-Dap-Phe (MMAF), préparés et fixés à des ligands par divers lieurs, comprenant le maléimidocaproyl-val-cit-PAB. Les conjugués médicament/ligand obtenus ont présenté une activité in vitro et in vivo.
Doronina Svetlana O.
Ebens Allen J.
Kline Toni Beth
Polakis Paul
Senter Peter D.
Seattle Genetics Inc.
Smart & Biggar
LandOfFree
Monomethylvaline compounds capable of conjugation to ligands does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Monomethylvaline compounds capable of conjugation to ligands, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Monomethylvaline compounds capable of conjugation to ligands will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1968780